[Angiotensin type 1 receptor blocker reduced proteinuria in patients of focal glomerular sclerosis].
Chihara
Yukana
Y
Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Japan.
Ono
Hidehiko
H
Ono
Yuko
Y
Inada
Hideki
H
Ueda
Yoshihiko
Y
Fujimori
Takahiro
T
Iidaka
Kazunari
K
Ishimitsu
Toshihiko
T
Rakugi
Hiromi
H
Ogihara
Toshio
T
Matsuoka
Hiroaki
H
D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D018753:Diet, Protein-Restricted; D004359:Drug Therapy, Combination; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019808:Losartan / Q000008:administration & dosage*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011507:Proteinuria / Q000209:etiology / Q000628:therapy*; D012074:Remission Induction; D012263:Ribonucleosides / Q000627:therapeutic use; D013777:Tetrazoles / Q000008:administration & dosage*; D014633:Valine / Q000008:administration & dosage* / Q000031:analogs & derivatives; D000068756:Valsartan
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D013777:Tetrazoles; C010052:mizoribine; D000068756:Valsartan; D011239:Prednisolone; D014633:Valine; D019808:Losartan; D008775:Methylprednisolone